Skip to main content
Equibles

BNTX · BioNTech SE · Earnings Call Transcripts & Audio

Track BNTX — free

Use BNTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BNTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$98.00 -0.57 (-0.58%) At close · Sep 30
Rebalance outlook locked
Market Cap
$24.76B
Shares
251.20M
Volume · Sep 30 845.79K Avg daily vol (3M) 1.14M

BioNTech SE Earnings Call Transcripts

Quarterly earnings calls for BioNTech SE (BNTX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q3
2026-11-03
BioNTech SE (BNTX) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-04
BioNTech SE (BNTX) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
BioNTech SE (BNTX) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-10
BioNTech SE (BNTX) Q4 2025 Earnings Call Transcript
Positive tone Oncology pipeline / Pumitamik (Bumitamik) Late-stage data readouts in 2026 BMS partnership & strategic deals
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript
Confident tone Pumitamig (PD-L1 VEGF-A bispecific) registrational progress mRNA cancer immunotherapy platform TPAM HER2 ADC program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
BioNTech SE (BNTX) Q1 2025 Earnings Call Transcript
Confident tone BNT327 Bispecific Antibody Pipeline Biotheus Acquisition HER2 ADC BNT323 BLA Submission
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
BioNTech SE (BNTX) Q4 2024 Earnings Call Transcript
Confident tone BNT327 pan-tumor oncology strategy Lung cancer clinical development Biotheus acquisition
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
BioNTech SE (BNTX) Q3 2024 Earnings Call Transcript
Confident tone BNT327 bispecific antibody (PD-L1/VEGF-A) mRNA cancer vaccine portfolio (FixVac and iNeST) COVID-19 vaccine franchise and strain adaptation
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
BioNTech SE (BNTX) Q2 2024 Earnings Call Transcript
Confident tone Oncology pipeline execution and mRNA cancer vaccines IO plus ADC combination strategy Regulatory submissions and approvals
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript
Positive tone Oncology pipeline and pivotal trials mRNA cancer vaccine platform COVID-19 vaccine franchise
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
BioNTech SE (BNTX) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
BioNTech SE (BNTX) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
BioNTech SE (BNTX) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
BioNTech SE (BNTX) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
BioNTech SE (BNTX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
BioNTech SE (BNTX) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
BioNTech SE (BNTX) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
BioNTech SE (BNTX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
BioNTech SE (BNTX) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
BioNTech SE (BNTX) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
BioNTech SE (BNTX) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
BioNTech SE (BNTX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
BioNTech SE (BNTX) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
BioNTech SE (BNTX) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
BioNTech SE (BNTX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 6 filings 6 filers Visit website Investor relations